Posted on February 21, 20232/21/23
Critical Success Factors for Launching Products with Orphan Drug Designation
Posted on August 19, 20228/19/22
Case Study: Leveraging machine learning models in patient identification and behavior prediction for rare disease indications
Posted on July 27, 20227/27/22
EVERSANA’s Continued Commitment to Rare Disease
Posted on May 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Posted on April 14, 20224/14/22
Impact of Patient Reported Outcome Measures on HTA Decisions for Rare Diseases
Posted on April 8, 20224/8/22
EVERSANA Featured in NIH Study Detailing the Cost of Treating Rare Disease
Posted on March 11, 20223/11/22
Gene Therapy in Today’s Digital World
Posted on January 26, 20221/26/22
Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem
Posted on October 14, 202110/14/21
Webinar: Discover Patient Support Program Needs for Patients with Rare Diseases
Posted on October 4, 202110/4/21